Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study.

"Declarations Ethics approval and consent to participateThis study was approved by the National Health Service (NHS) National Research Ethics Service (11/NW/0382) and the UK Biobank Ethics and Governance Council. All participants provided written informed consent before taking part in the study. Consent for publicationAll participants in UK biobank provided informed consent through electronic signature at the first assessment. Competing interestsAuthors have disclosed no competing interests. Competing interests Authors have disclosed no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China, Major Joint Project (U21A20355). National key research & development plan of China, major project of prevention and treatment for common diseases (2022YFC2505300, sub-project: 2022YFC2505301, 2022YFC2505302, 2022YFC2505306). The National Natural Science Foundation of China (82270878, 81870567, 81970720, 82170825). Youth Foundation of the National Natural Science Foundation (82000744). Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission (Major Project, 2022ZDXM003). National key research & development plan of China, major project of prevention and treatment for common diseases (2021YFC2501600, sub-project: 2021YFC2501603). The Chongqing Science and Health Joint Medical Research Project (2020FYYX141). The Innovative Funded Project of Chongqing Innovation and Retention Program (cx2019032). The Chongqing Yong and Middle-aged Senior Medical Talents Studio (ZQNYXGDRCGZS2021001). Chongqing Outstanding Youth Funds (cstc2019jcyjjq0006). Program for Youth Innovation in Future Medicine, Chongqing Medical University (Jinbo Hu and Rufei Gao). Program for Major Scientific and Technological Talents, Chongqing Medical University (Jinbo Hu and Shumin Yang). Science and Technology Research Project of Chongqing Education Commission (Grant No. KJQN202200403)."